In the intention-to-treat population, the incidence of polymerase chain reaction-confirmed SARS-CoV-2 infection was significantly lower in the azelastine group vs the placebo group. HealthDay News — ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...

SARS-CoV-2 infection is linked with early vascular aging in the long term, especially in women, according to a recent study in the European Heart Journal. In the multicenter CARTESIAN study, ...

The COVID-19 virus hijacks the machinery of testicular cells that produce the hormone testosterone in order to replicate. It also appropriates the metabolic pathways of these cells and cholesterol, a ...

The cocirculation and infection of SARS-CoV-2 and influenza A viruses significantly impact the transmission dynamics of infectious diseases and increase the public health burden on communities.

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...

New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...

NEW YORK – Becton Dickinson announced on Wednesday that its Veritor 15-minute point-of-care test for SARS-CoV-2 has obtained 510(k) clearance from the US Food and Drug Administration. The BD Veritor ...

A bottleneck to enabling widespread access to molecular diagnostics, especially in low- and middle-income countries, has been the high cost and complex logistics associated with rapid point-of-care ...